Objective: To determine the e cacy and cut-o values of C-reactive protein (CRP), lactate dehydrogenase (LDH), serum ferritin, and D-dimer for predicting mortality of COVID-19 infection. Study Design: Observational study. Place and Duration of Study: Department of Medicine, Jinnah Hospital, Lahore from January to May 2021. Methodology: Serum CRP, LDH, ferritin, and D-dimer were measured in patients with moderate to severe COVID-19 infection at admission. Patients were followed for in-hospital disease outcome. ROC curve was used to determine area under curve (AUC) and cut-o values of biomarkers, followed by multi-variate analysis by logistic regression. Results: In 386 patients, male to female ratio was 1.47/1 (230/156); and mean age was 54.03 ± 16.2 years. Disease was fatal in 135 (35%) patients. AUC for mortality was 0.730 for LDH, 0.737 for CRP, 0.747 for ferritin and 0.758 for D-dimer. Mortality was higher with LDH e400 U/ml, Odds Ratio (OR) 5.37 (95% CI 3.01-9.57: p = 0.001), CRP e30 ng/L, OR 4.30 (95% CI 2.11-8.74: p = <0.001), serum ferritin e200 ng/ml, OR 4.13 (95% CI 1.05-16.2: p = 0.02), and D-dimer e400 ng/ml, OR 2.72 (95% CI 1.06-7.01: p = 0.03) with 2 log likelihood of 131.54 for predicting disease outcome with 71.7% accuracy in multi-variate analysis. Conclusion: Elevated serum CRP, LDH, ferritin and D-dimer are associated with higher mortality in patients of COVID-19 infection. Serum CRP e30ng/ml, LDH e400 U/L, ferritin e200 ng/ml and D-dimer e400 ng/ml can predict fatal outcome in COVID-19 patients.